Search PubMedSearch

PubMed · 803151

Primary femininity.

Abstract

In Freud's theory of the origins of femininity in females, there is a stage unaccounted for in the chronology of the little girl's development: the first many months of life are not considered. We know by now that castration anxiety, penis envy, and the traumas and frustrations of oedipal conflict are easy to demonstrate; but if the first stage in female development is different from Freud's description-if a fundamental, fixed sense of being rightfully a female is established in earliest childhood-then our psychology of women needs repair. The factors that make up this stage, with examples, are reviewed: (1) a biological "force": the effect of circulating fetal sex hormones on the brain of the fetus; (2) sex assignment: the announcement at the time of birth to the parents that they have had a boy or a girl (or a hermaphrodite); (3) parental attitudes: the effects of the sex assignment on parents, then reflected back onto the infant; (4) "biopsychic" phenomena: early postnatal effects caused by certain habitual patterns of handling the infant-conditioning, imprinting(?), or other forms of nonconflictual learning; (5) developing body ego: sensations, especially from the genitals, that define the child's dimensions. I suggest that one can divide the development of femininity in females into two phases, both of which lead to adult femininity, but each of which contributes in a different manner. The first, nonconflictual in origin, contributes a sense of femaleness and some of what allows for one's looking feminine; the second, the result of conflict, especially oedipal, produces a richer and more complicated femininity, not merely one of appearances, but one enriched by desires to perform with the substance, rather than just the façade, of femininity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R J Stoller. 1976. Primary femininity.. https://pubmed.ncbi.nlm.nih.gov/803151/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prevalence and risk factors for persistent faecal carriage of extended spectrum beta-lactamase producing Escherichia coli in a paediatric community population.

OBJECTIVE: To investigate clinical and microbiological factors associated with persistent faecal carriage of extended spectrum beta-lactamase (ESBL) producing Escherichia coli in infants. METHODS: Between 2010 and 2022, children aged 3 months to 2 years old were sampled in a community setting in France, at two visits, V1 and V2, 3-24 months apart, to screen for prolonged faecal carriage of ESBL-producing E. coli. Patient clinical information and whole genome sequence of each isolate were used for association studies. RESULTS: A total of 4641 children were sampled. 375 (8%) carried an ESBL-producing Enterobacterales, among which 142 of ESBL-producing E. coli carriers were once again sampled at V2 and included in this study. 21.8% (n = 31/142) and 18.4% (n = 16/99) carried the same ESBL-producing E. coli clone for at least 3 and 6 months, respectively. B2 phylogroup, and among which ST131 clones were associated with an increased risk of persistent carriage. Multivariate analysis identified virulence associated genes involved in adhesion (papC/papGII allele and a tia-like gene) and encoding toxin (senB) as major risk factors for persistence. A genome wide association study highlighted the potential role of the frz metabolic operon, known to be involved in enterocytes adhesion/internalisation. CONCLUSION: Main extraintestinal pathogenic E. coli genomic features (phylogenetic background, adhesion properties) are associated with ESBL-producing E. coli gut colonisation persistence in infants, which could potentially lead to an increased risk of febrile urinary tract infection in these patients.

Child

Extensive and differential platinum chemotherapy mutagenesis in livers of children.

Childhood cancer survivors often experience late adverse effects that may be linked to chemotherapy mutagenesis. We studied chemotherapy mutagenesis in normal pediatric tissues using duplex sequencing (NanoSeq) to enable the detection of mutations from single DNA molecules. We found that platinum chemotherapeutics increased the mutation burdens of normal pediatric tissues to levels seen in adults. In the liver, platinum agents imparted a tissue-specific mutational signature that was absent from other tissues. Gene-focused duplex sequencing revealed that chemotherapy mutagenesis generates a great diversity of nonsynonymous variants, some of which may have functional potential, such as leukemogenic variants in blood. Our findings demonstrate extensive chemotherapy mutagenesis in normal tissues of children, which may provide a plausible link between chemotherapy exposure and adverse effects in later life.

Child

Clinical and immunological characterization of a child with a homozygous TBK1 kinase-domain truncation.

TBK1 is a serine-tyrosine kinase protein that transmits signals from pattern recognition receptors to the NF-κB pathway leading to production of Type 1 Interferons. Mutations in this protein have been associated with arthritis, vasculitis, herpes simplex encephalitis and amyotrophic lateral sclerosis. In the current study, we characterized the functional consequences of a TBK1-variant bearing a truncation in exon 4 and 5 in a patient with poly arthritis resembling juvenile idiopathic arthritis and necrotizing encephalitis. The truncation was associated with reduced TBK1 protein abundance and altered phosphorylation. The variant was associated with increased basal/and or Poly-I: C induced IL-6, TNFα, IL-1β and IL-18 and type 1 Interferon ex vivo. Our findings expand the phenotypic spectrum of TBK1 loss-of-function variants and may provide insight into the management of immune dysregulation in affected patients.

Child